Lean Body Mass as a Predictor of Drug Dosage
- 1 April 1994
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 26 (4) , 292-307
- https://doi.org/10.2165/00003088-199426040-00005
Abstract
There is mounting evidence to suggest that lean body mass (LBM) may be a better predictor of drug dosage than either total bodyweight (TBW) or body surface area (BSA), although the rationale for this...Keywords
This publication has 98 references indexed in Scilit:
- Clinical Pharmacokinetics of Drugs in ObesityClinical Pharmacokinetics, 1993
- Relationship of Bioelectrical Impedance to Pharmacokinetic Parameters of Theophylline in Healthy MalesClinical Pharmacokinetics, 1989
- Intravenous Phenytion Loading in Patients after Neurosurgery and in Status EpilepticusClinical Pharmacokinetics, 1988
- Drug Disposition in Obese HumansClinical Pharmacokinetics, 1986
- Cloxacillin absorption and disposition in cystic fibrosisThe Journal of Pediatrics, 1984
- Population Pharmacokinetics of Procainamide from Routine Clinical DataClinical Pharmacokinetics, 1984
- Pharmacokinetics of Drugs in ObesityClinical Pharmacokinetics, 1982
- Disposition of Antipyrine and Phenytoin Correlated with Age and Liver Volume in ManClinical Pharmacokinetics, 1981
- Oral theophylline dosage for the management of chronic asthmaThe Journal of Pediatrics, 1978
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976